Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia

NCT02035215 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia, Familial Combined

Interventions

DRUG: Atorvastatin 20mg
DRUG: Omega-3-acids ethylesters 90 4g
OTHER: Placebo(Omega-3-acids ethylesters 90)

Sponsor

Kuhnil Pharmaceutical Co., Ltd.